These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 31314122)
1. Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option. Hotz C; Sbidian E; Ingen-Housz-Oro S; Chosidow O; Wolkenstein P Acta Derm Venereol; 2019 Nov; 99(12):1170-1171. PubMed ID: 31314122 [No Abstract] [Full Text] [Related]
2. Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab. Schuch A; Fischer T; Boehner A; Biedermann T; Volz T Acta Derm Venereol; 2018 Jan; 98(1):151-152. PubMed ID: 28902952 [No Abstract] [Full Text] [Related]
3. Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients. Weber P; Seyed Jafari SM; Yawalkar N; Hunger RE J Am Acad Dermatol; 2017 Jun; 76(6):1189-1191. PubMed ID: 28522043 [No Abstract] [Full Text] [Related]
4. Recalcitrant severe hidradenitis suppurativa successfully treated with cyclosporine A. Bianchi L; Hansel K; Stingeni L J Am Acad Dermatol; 2012 Dec; 67(6):e278-9. PubMed ID: 23158638 [No Abstract] [Full Text] [Related]
5. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial. Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320 [TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug? Vekic DA; Frew JW Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755 [No Abstract] [Full Text] [Related]
7. Long-term therapy with anakinra in hidradenitis suppurativa in three patients. André R; Marescassier H; Gabay C; Pittet B; Laffitte E Int J Dermatol; 2019 Nov; 58(11):e208-e209. PubMed ID: 31353451 [No Abstract] [Full Text] [Related]
8. Apremilast for the Treatment of Mild-to-Moderate Hidradenitis Suppurativa in a Prospective, Open-Label, Phase 2 Study. Kerdel FR; Azevedo FA; Kerdel Don C; Don FA; Fabbrocini G; Kerdel FA J Drugs Dermatol; 2019 Feb; 18(2):170-176. PubMed ID: 30811140 [TBL] [Abstract][Full Text] [Related]
9. Guselkumab in the treatment of hidradenitis suppurativa: A retrospective chart review. Casseres RG; Kahn JS; Her MJ; Rosmarin D J Am Acad Dermatol; 2019 Jul; 81(1):265-267. PubMed ID: 30562567 [No Abstract] [Full Text] [Related]
10. Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders. Aarts P; Vossen ARJV; van der Zee HH; Prens EP; van Straalen KR J Am Acad Dermatol; 2021 Jul; 85(1):258-260. PubMed ID: 32891782 [No Abstract] [Full Text] [Related]
11. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab. Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787 [TBL] [Abstract][Full Text] [Related]
12. Hidradenitis suppurativa complicated by squamous cell carcinoma: isoscartopic response. Caccavale S; Caccavale T; La Montagna M Int Wound J; 2017 Dec; 14(6):1397-1398. PubMed ID: 28544759 [No Abstract] [Full Text] [Related]
13. Bacteriology of hidradenitis suppurativa/acne inversa: A review. Nikolakis G; Join-Lambert O; Karagiannidis I; Guet-Revillet H; Zouboulis CC; Nassif A J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S12-8. PubMed ID: 26470608 [TBL] [Abstract][Full Text] [Related]
15. A case of hidradenitis suppurativa successfully treated with apremilast in a patient with psoriasis and SAMPUS. Proietti I; Michelini S; Mambrin A; Di Fraia M; Tolino E; Balduzzi V; Bernardini N; Marchesiello A; Porta N; Skroza N; Romeo G; Di Cristofano C; Petrozza V; Potenza C Dermatol Ther; 2020 May; 33(3):e13448. PubMed ID: 32323441 [No Abstract] [Full Text] [Related]
16. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate. De Souza A; Solomon GE; Strober BE Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400 [TBL] [Abstract][Full Text] [Related]
17. Infliximab for the treatment of hidradenitis suppurativa. Fernández-Vozmediano JM; Armario-Hita JC Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838 [TBL] [Abstract][Full Text] [Related]
18. Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience. Bettoli V; Manfredini M; Calamo G; Forconi R; Bencivelli D; Mantovani L; Pellacani G; Corazza M Dermatol Ther; 2018 Nov; 31(6):e12737. PubMed ID: 30295378 [No Abstract] [Full Text] [Related]
19. Hemoglobin as an indicator of disease activity in severe hidradenitis suppurativa. Braunberger TL; Lowes MA; Hamzavi IH Int J Dermatol; 2019 Sep; 58(9):1090-1091. PubMed ID: 30094834 [No Abstract] [Full Text] [Related]
20. Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review. Meskin SW; Carlson EM Ocul Immunol Inflamm; 2011 Oct; 19(5):340-2. PubMed ID: 21823931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]